Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: A comprehensive study on six breast cell lines with varying phenotypes

Journal of Biomedical Optics

Volumn 15, Issue 1, 2010, Pages

  Millon, Stacy R ^a   Ostrander, Julie H ^b   Yazdanfar, Siavash ^c   Quincy Brown, J ^a   Bender, Janelle E ^a   Rajeha, Anita ^a   Ramanujam, Nirmala ^a  

^a Duke University   (United States)

^b DUKE UNIVERSITY   (United States)

^c GE GLOBAL RESEARCH   (United States)

Author keywords

5 Aminolevulinic acid; Breast cells; Confocal microscopy; Fluorescence intensity; Protoporphyrin IX; Spectroscopy

Indexed keywords

5-AMINOLEVULINIC ACID; BREAST CANCER; BREAST CANCER CELLS; BREAST CELLS; BREAST TUMOR; CELL LINES; COMPREHENSIVE STUDIES; CONTRAST MECHANISM; ENDOGENOUS FLUORESCENCE; ESTROGEN RECEPTOR; FLAVIN ADENINE DINUCLEOTIDE; FLUORESCENCE INTENSITIES; FLUORESCENCE INTENSITY; MAMMARY EPITHELIAL CELLS; POST TREATMENT; PROTOPORPHYRIN IX; SPECTRAL IMAGING; STATISTICALLY SIGNIFICANT DIFFERENCE;

CELL CULTURE; CONFOCAL MICROSCOPY; DISEASES; FLUORESCENCE;

CELLS;

AMINOLEVULINIC ACID; CONTRAST MEDIUM; PROTOPORPHYRIN;

ANALYSIS OF VARIANCE; ARTICLE; BREAST TUMOR; CHEMISTRY; CONFOCAL MICROSCOPY; FEMALE; HUMAN; METABOLISM; METHODOLOGY; PHENOTYPE; SPECTROFLUOROMETRY; TUMOR CELL LINE;

AMINOLEVULINIC ACID; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; HUMANS; MICROSCOPY, CONFOCAL; PHENOTYPE; PROTOPORPHYRINS; SPECTROMETRY, FLUORESCENCE;

EID: 77953156692     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3302811     Document Type: Article

References (51)

1. N. Cabioglu, K. Hunt, A. Sahin, and H. Kuerer, "Role for intraoperative margin assessment in patients undergoing breast-conserving surgery", Ann. Surg. Oncol. 14, 1458-1471 (2007). (Pubitemid 46536814)
2. M. R. Bani, M. P. Lux, K. Heusinger, E. Wenkel, A. Magener, R. Schulz-Wendtland, M. W. Beckmann, and P. A. Fasching, "Factors correlating with reexcision after breast-conserving therapy", Eur. J. Surg. Oncol. 35(1), 32-37 (2009).
3. M. F. Dillon, E. W. McDermott, A. O'Doherty, C. M. Quinn, A. D. Hill, and N. O'Higgins, "Factors affecting successful breast conservation for ductal carcinoma in situ", Ann. Surg. Oncol. 14(5), 1618-28 (2007). (Pubitemid 46790985)
4. B. D. Florentine, N. K. Kaushal, M. R. Puig, N. Sarda, G. Senofsky, B. T. Cooper, A. Black, R. Zimmerman, and J. Barstis, "Breastconservation treatment outcomes: a community hospital's experience", Breast J. 15(1), 76-84 (2009).
5. T. L. Huston, R. Pigalarga, M. P. Osborne, and E. Tousimis, "The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery", Am. J. Surg. 192(4), 509-512 (2006). (Pubitemid 44344190)
6. E. D. Kurniawan, M. H. Wong, I. Windle, A. Rose, A. Mou, M. Buchanan, J. P. Collins, J. A. Miller, R. L. Gruen, and G. B. Mann, "Predictors of surgical margin status in breast-conserving surgery within a breast screening program", Ann. Surg. Oncol. 15(9), 2542-2549 (2008).
7. S. A. McLaughlin, L. M. Ochoa-Frongia, S. M. Patil, H. S. Cody, 3rd, and L. M. Sclafani, "Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy", J. Am. Coll. Surg. 206(1), 76-82 (2008). (Pubitemid 350267257)
8. J. E. Mendez, W. W. Lamorte, A. de Las Morenas, S. Cerda, R. Pistey, T. King, M. Kavanah, E. Hirsch, and M. D. Stone, "Influence of breast cancer margin assessment method on the rates of positive margins and residual carcinoma", Am. J. Surg. 192(4), 538-540 (2006). (Pubitemid 44344200)
9. T. S. Menes, P. I. Tartter, I. Bleiweiss, J. H. Godbold, A. Estabrook, and S. R. Smith, "The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients", Ann. Surg. Oncol. 12(11), 881-885 (2005). (Pubitemid 41504220)
10. J. F. Waljee, E. S. Hu, L. A. Newman, and A. K. Alderman, "Predictors of re-excision among women undergoing breast-conserving surgery for cancer", Ann. Surg. Oncol. 15(5), 1297-1303 (2008).
11. A. W. Lin, N. A. Lewinski, J. L. West, N. J. Halas, and R. A. Drezek, "Optically tunable nanoparticle contrast agents for early cancer detection: model-based analysis of gold nanoshells", J. Biomed. Opt. 10(6), 064035 (2005).
12. K. Sokolov, D. Nida, M. Descour, A. Lacy, M. Levy, B. Hall, S. Dharmawardhane, A. Ellington, B. Korgel, and R. Richards-Kortum, "Molecular optical imaging of therapeutic targets of cancer", Adv. Cancer Res. 96, 299-344 (2007).
13. M. Veiseh, P. Gabikian, S. B. Bahrami, O. Veiseh, M. Zhang, R. C. Hackman, A. C. Ravanpay, M. R. Stroud, Y. Kusuma, S. J. Hansen, D. Kwok, N. M. Munoz, R. W. Sze, W. M. Grady, N. M. Greenberg, R. G. Ellenbogen, and J. M. Olson, "Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci", Cancer Res. 67(14), 6882-6888 (2007). (Pubitemid 47105535)
14. E. Uzgiris, A. Sood, K. Bove, B. Grimmond, D. Lee, and S. Lomnes, "A multimodal contrast agent for preoperative MR imaging and intraoperative tumor margin delineation", Technol. Cancer Res. Treat. 5(4), 301-309 (2006). (Pubitemid 44300245)
15. K. A. Frei, H. M. Bonel, H. Frick, H. Walt, and R. A. Steiner, "Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer", Br. J. Cancer 90(4), 805-809 (2004). (Pubitemid 38406590)
16. E. R. Gallegos, I. DeLeon Rodriguez, L. A. Martinez Guzman, and A. J. Perez Zapata, "In vitro study of biosynthesis of protoporphyrin IX induced by delta-aminolevulinic acid in normal and cancerous cells of the human cervix", Arch. Med. Res. 30(3), 163-170 (1999). (Pubitemid 29352166)
17. F. Gamarra, S. Wagner, S. Al-Batran, I. Maier, M. Castro, H. Hautmann, A. Bergner, R. Baumgartner, and R. M. Huber, "Kinetics of 5-aminolevulinic acid-induced fluorescence in organ cultures of bronchial epithelium and tumor", Respiration 69(5), 445-450 (2002).
18. S. L. Gibbs, B. Chen, J. A. O'Hara, P. J. Hoopes, T. Hasan, and B. W. Pogue, "Protoporphyrin IX level correlates with number of mitochondria, but increase in production correlates with tumor cell size", Photochem. Photobiol. 82(5), 1334-1341 (2006). (Pubitemid 44702017)
19. H. Hirschberg, D. Sorensen, E. Angell-Petersen, Q. Peng, B. Tromberg, C. Sun, S. Spetalen, and M. S, "Repetitive photodynamic therapy of malignant brain tumors", J. Environ. Pathol. Toxicol. Oncol. 25(1-2), 261-279. (2006). (Pubitemid 43341246)
20. Z. Ji, G. Yang, V. Vasovic, B. Cunderlikova, Z. Suo, J. M. Nesland, and Q. Peng, "Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines", J. Photochem. Photobiol, B 84(3), 213-220 (2006). (Pubitemid 44184915)
21. C. Klinteberg, A. Enejder, I. Wang, S. Andersson-Engels, S. Svanberg, and K. Svanberg, "Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas", J. Photochem. Photobiol. B: Biol. 49, 120-128 (1999). (Pubitemid 29267481)
22. B. Krammer and K. Plaetzer, "ALA and its clinical impact from benchside to bedside", Photochem. Photobiol. Sci. 7(3), 283-289 (2008). (Pubitemid 351501306)
23. R. C. Krieg, H. Messmann, J. Rauch, S. Seeger, and R. Knuechel, "Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells", Photochem. Photobiol. 76(5), 518-525 (2002).
24. D. P. Ladner, R. A. Steiner, J. Allemann, U. Haller, and H. Walt, "Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid", Br. J. Cancer 84(1), 33-37 (2001). (Pubitemid 32102500)
25. A. Leunig, K. Rick, H. Stepp, R. Gutmann, G. Alwin, R. Baumgartner, and J. Feyh, "Fluorescence imaging and spectroscopy of 5-aminolevulinic acid induced protoporphyrin IX for the detection of neoplastic lesions in the oral cavity", Am. J. Surg. 172(6), 674-677 (1996). (Pubitemid 27024777)
26. H. Messmann, R. Knuchel, W. Baumier, A. Holstege, and J. Scholmerich, "Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization", Gastrointest. Endosc. 49(1), 1-5 (1999).
27. R. Na, I. Stender, and H. Wulf, "Can autofluorescence demarcate basal cell carcinoma from normal skin? A comparison with protoporphyrin IX fluorescence", Acta Derm Venereol 81, 246-249 (2001). (Pubitemid 32977101)
28. N. Navone, C. Polo, A. Frisardi, N. Andrade, and A. Battle, "Heme biosynthesis in human breast cancer-mimetic in vitro studies and some heme enzymic activity levels", Int. J. Biochem. 22(12), 1407-1411 (1990). (Pubitemid 20370322)
29. L. Rodriguez, G. Divenosa, A. Batlle, A. Macrobert, and A. Casas, "Response to ALA-based PDT in an immortalised normal breast cell line and its counterpart transformed with the Ras oncogene", Photochem. Photobiol. Sci. 6(12), 1306-1310 (2007). (Pubitemid 350191099)
30. R. Sailer, W. S. Strauss, M. Wagner, H. Emmert, and H. Schneckenburger, "Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines", Photochem. Photobiol. Sci. 6(2), 145-151 (2007). (Pubitemid 46233591)
31. A. Sharwani, W. Jerjes, V. Salih, A. J. MacRobert, M. El-Maaytah, H. S. Khalil, and C. Hopper, "Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in detecting oral premalignancy", J. Photochem. Photobiol, B 83(1), 27-33 (2006). (Pubitemid 43372639)
32. K. T. Moesta, B. Ebert, T. Handke, D. Nolte, C. Nowak, W. E. Haensch, R. K. Pandey, T. J. Dougherty, H. Rinneberg, and P. M. Schlag, "Protoporphyrin IX occurs naturally in colorectal cancers and their metastases", Cancer Res. 61(3), 991-999 (2001). (Pubitemid 32174416)
33. S. Andersson-Engels, G. Canti, R. Cubeddu, C. Eker, C. Klinteberg, A. Pifferi, K. Svanberg, S. Svanberg, P. Taroni, G. Valentini, and I. Wang, "Preliminary evaluation of two fluorescence imaging methods for the detection and the delineation of basal cell carcinomas of the skin", Lasers Surg. Med. 26(1), 76-82 (2000). (Pubitemid 30054275)
34. C. S. Betz, H. Stepp, P. Janda, S. Arbogast, G. Grevers, R. Baumgartner, and A. Leunig, "A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis", Int. J. Cancer 97(2), 245-252 (2002). (Pubitemid 34019962)
35. J. Y. Chen, N. Q. Mak, N. H. Cheung, R. N. Leung, and Q. Peng, "Endogenous production of protoporphyrin IX induced by 5-aminolevulinic acid in leukemia cells", Acta Pharmacol. Sin. 22(2), 163-168 (2001). (Pubitemid 32158356)
36. A. M. Dorward, K. S. Fancher, T. M. Duffy, W. G. Beamer, and H. Walt, "Early neoplastic and metastatic mammary tumours of transgenic mice detected by 5-aminolevulinic acid-stimulated protoporphyrin IX accumulation", Br. J. Cancer 93(10), 1137-1143 (2005). (Pubitemid 41670698)
37. N. Fotinos, M. A. Campo, F. Popowycz, R. Gurny, and N. Lange, "5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives", Photochem. Photobiol. 82(4), 994-1015 (2006). (Pubitemid 44450185)
38. Y. Berger, C. Chapuis Bernasconi, F. Schmitt, R. Neier, and L. Juillerat-Jeanneret, "Determination of intracellular prolyl/glycyl proteases in intact living human cells and protoporphyrin IX production as a reporter system", Chem. Biol. 12(8), 867-872 (2005). (Pubitemid 41206800)
39. M. G. Alvarez, M. S. Lacelli, V. Rivarola, A. Batlle, and H. Fukuda, "5-aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells", J. Environ. Pathol. Toxicol. Oncol. 26(2), 75-82 (2007). (Pubitemid 47295559)
40. S. Wu, Q. Ren, M. Zhou, Y. Wei, and J. Chen, "Photodynamic effects of 5-aminolevulinic acid and its hexylester on several cell lines", Sheng Wu Hua Xue Yu Shen Wu Wu Li Xue Bao 35(7), 655-660 (2003). (Pubitemid 36980883)
41. D. Zaak, D. Frimberger, H. Stepp, S. Wagner, R. Baumgartner, P. Schneede, M. Siebels, R. Knuchel, M. Kriegmair, and A. Hofstetter, "Quantification of 5-aminolevulinic acid induced fluorescenc improves the specificity of bladder cancer detection", J. Urol. (Baltimore) 166(5), 1665-1668 (2001).
42. European Public Assessment Report: Gliolan Available from (http://www.emea.europa.eu/humandocs/PDFs/EPAR/gliolan/H-744-en1.pdf) (2007).
43. T. Tsai, H. T. Ji, P. C. Chiang, R. H. Chou, W. S. Chang, and C. T. Chen, "ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells", Lasers Surg. Med. 41(4), 305-315 (2009).
44. S. Anandappa, R. Sibson, A. Platt-Higgins, J. Winstanley, P. Rudland, and R. Barraclough, "Variant estrogen receptor alpha mRNAs in human breast cancer specimens", Int. J. Cancer 88, 209-216 (2000).
45. (www.protocol-online.org/biology-forums/posts/5763.htm) (2008).
46. R. S. DaCosta, H. Andersson, and B. C. Wilson, "Molecular fluorescence excitation-emission matrices relevant to tissue spectroscopy", Photochem. Photobiol. 78(4), 384-392 (2003).
47. E. C. Dietze, M. M. Troch, G. R. Bean, J. B. Heffner, M. L. Bowie, P. Rosenberg, B. Ratliff, and V. L. Seewaldt, "Tamoxifen and tamoxifen ethyl bromide induce apoptosis in acutely damaged mammary epithelial cells through modulation of AKT activity", Oncogene 23(21), 3851-3862 (2004). (Pubitemid 38725698)
48. I. Wang, L. Clemente, R. Pratas, E. Cardoso, M. Clemente, S. Montan, S. Svanberg, and K. Svanberg, "Fluorescence diagnostics and kinetics studies in the head and neck region utilizing low-dose d-aminolevulinic acid sensitization", Cancer Lett. 135(11-9), 1-8 (1999).
49. S. L. Gibbs-Strauss, J. A. O'Hara, P. J. Hoopes, T. Hasan, and B. W. Pogue, "Noninvasive measurement of aminolevulinic acid-induced protoporphyrin IX fluorescence allowing detection of murine glioma in vivo", J. Biomed. Opt. 14(1), 014007 (2009).
50. J. M. Rae, C. J. Creighton, J. M. Meck, B. R. Haddad, and M. D. Johnson, "MDA-MB-435 are derived from M-14 melanoma cells-a loss for breast cancer, but a boon for melanoma research", Breast Cancer Res. Treat. 104(1), 13-19 (2007). (Pubitemid 46976633)
51. A. F. Chambers, "MDA-MB-435 and M14 cell lines: Identical but not M14 melanoma?" Cancer Res. 69(13), 5292-5293 (2009).